SEC Form 4 · accession 0001209191-15-086363
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lauren M Sabella
Officer — Chief Commercial Officer
Period of report
Dec 17, 2015
Accepted (ET)
Dec 21, 2015 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 17, 2015 | M | 14,229 | $22.06 | A | 28,607 | D | |
| Common StockF1 | Dec 17, 2015 | S | 14,229 | $40.00 | D | 14,378 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F2 | $22.06 | Dec 17, 2015 | M | 14,229 | D | — | Mar 3, 2021 | Common Stock | 14,229 | 16,709 | D |
Explanation of responses
- F1Exercise and sales pursuant to a 10b5-1 plan.
- F2The shares subject to these options vested in installments and were fully vested on January 1, 2015.